Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Gross ProfitOther Operating ExpensesRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Mainz Biomed N.V (MYNZ) Consolidated Net Income: 2022-2023

Historic Consolidated Net Income for Mainz Biomed N.V (MYNZ) over the last 2 years, with Dec 2023 value amounting to -$5.2 million.

  • Mainz Biomed N.V's Consolidated Net Income rose 36.70% to -$5.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was -$26.3 million, marking a year-over-year increase of 0.35%. This contributed to the annual value of -$21.7 million for FY2024, which is 17.66% up from last year.
  • Mainz Biomed N.V's Consolidated Net Income amounted to -$5.2 million in Q4 2023, which was up 17.72% from -$6.3 million recorded in Q3 2023.
  • Mainz Biomed N.V's 5-year Consolidated Net Income high stood at -$5.2 million for Q4 2023, and its period low was -$8.3 million during Q2 2023.
  • For the 2-year period, Mainz Biomed N.V's Consolidated Net Income averaged around -$6.6 million, with its median value being -$6.4 million (2023).
  • Within the past 5 years, the most significant YoY rise in Mainz Biomed N.V's Consolidated Net Income was 36.70% (2023), while the steepest drop was 18.92% (2023).
  • Over the past 2 years, Mainz Biomed N.V's Consolidated Net Income (Quarterly) stood at -$8.2 million in 2022, then skyrocketed by 36.70% to -$5.2 million in 2023.
  • Its Consolidated Net Income stands at -$5.2 million for Q4 2023, versus -$6.3 million for Q3 2023 and -$8.3 million for Q2 2023.